|
Volumn 17, Issue 3, 2009, Pages 171-174
|
[A study on the treatment of chronic hepatitis B with YMDD mutation].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
ADENINE;
ALANINE AMINOTRANSFERASE;
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
ENTECAVIR;
GUANINE;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PHOSPHONIC ACID DERIVATIVE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS DNA;
ADULT;
ANTIVIRAL RESISTANCE;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
GENETICS;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
MUTATION;
RANDOMIZED CONTROLLED TRIAL;
VIROLOGY;
ADENINE;
ADULT;
ALANINE TRANSAMINASE;
ANTIVIRAL AGENTS;
DNA, VIRAL;
DRUG RESISTANCE, VIRAL;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GUANINE;
HEPATITIS B E ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
LAMIVUDINE;
MALE;
MIDDLE AGED;
MUTATION;
PHOSPHONIC ACIDS;
REVERSE TRANSCRIPTASE INHIBITORS;
YOUNG ADULT;
|
EID: 79951945100
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|